HOME › DRUGS › NIRMATRELVIR;RITONAVIR
ACTIVE SUBSTANCE / INN

NIRMATRELVIR;RITONAVIR

Brand name(s): Paxlovid
EMA LISTED
AUTHORISED
COVID-19 virus infection
ACTIVE SUBSTANCE
Nirmatrelvir;Ritonavir
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PaxlovidPfizer Europe MA EEIGAuthorised28/01/2022COVID-19 virus infection

FULL INTELLIGENCE ON NIRMATRELVIR;RITONAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →